Welcome
Who are we ?
Press Releases
Documentation
Documentation
Corporate Presentation
Universal registration document
Financial report
Financial operations
Regulated information
Shares and voting rights
Liquidity contract
Share buyback programme
Directors’ disclosure
Shareholders
Shareholders
General meeting
General Meeting of June 6, 2024
General Meeting of June 1st, 2023
General Meeting of june 2, 2022
Shareholder letters
Shareholding structure
Financial calendar
Stock information
Analyst coverage
Contacts
Select your language
FR
EN
THERAVET
The specialist of osteoarticular
disease treatments in companion animals
Press releases
05/07/2024 - 07:30
TheraVet unveils its development strategy to address the equine market
04/23/2024 - 07:30
TheraVet reports Full-Year 2023 Financial Results and provides the preparatory documents for the General Meeting of June 6th, 2024
04/10/2024 - 07:45
TheraVet reports 2023 full year and 2024 first quarter revenues
03/13/2024 - 07:30
BIOCERA-VET® is now available for the management of dental and orthopedics conditions in horses
02/20/2024 - 07:30
TheraVet retains a leading US veterinary consulting firm to help strategize Company growth on the US market
01/30/2024 - 07:30
TheraVet strengthens its intellectual property with the issuance of a patent on VISCO-VET technology in Europe, Israël & Singapore
All press releases
Suscribe to the Newsletter
Ask us your questions